Who makes Step 2: TS-142?

Step 2: TS-142 is developed by Taisho Pharmaceutical Co., Ltd..

Last reviewed 2026-04-19 · How we verify

Step 2: TS-142

Taisho Pharmaceutical Co., Ltd. · Phase 2 active Small molecule

At a glance

Generic name	Step 2: TS-142
Sponsor	Taisho Pharmaceutical Co., Ltd.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy Subjects (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Step 2: TS-142 CI brief — competitive landscape report
Step 2: TS-142 updates RSS · CI watch RSS
Taisho Pharmaceutical Co., Ltd. portfolio CI